Yijiang Shi - Search Results

Year	Number of Results
2002	5
2003	3
2004	4
2005	3
2006	3
2007	1
2008	1
2009	2
2010	2
2011	1
2012	1
2013	3
2014	2
2016	2
2017	1
2019	1
2022	2
2023	1
2024	0

1

Dysregulation of SWI/SNF Chromatin Remodelers in NSCLC: Its Influence on Cancer Therapies including Immunotherapy.

Shi Y, Shin DS. Shi Y, et al. Biomolecules. 2023 Jun 13;13(6):984. doi: 10.3390/biom13060984. Biomolecules. 2023. PMID: 37371564 Free PMC article. Review.

2

Brief co-incubation of sperm and oocytes for in vitro fertilization techniques.

Huang Z, Li J, Wang L, Yan J, Shi Y, Li S. Huang Z, et al. Among authors: shi y. Cochrane Database Syst Rev. 2013 Apr 30;(4):CD009391. doi: 10.1002/14651858.CD009391.pub2. Cochrane Database Syst Rev. 2013. PMID: 23633370 Review.

3

Critical Role for Cap-Independent c-MYC Translation in Progression of Multiple Myeloma.

Shi Y, Sun F, Cheng Y, Holmes B, Dhakal B, Gera JF, Janz S, Lichtenstein A. Shi Y, et al. Mol Cancer Ther. 2022 Apr 1;21(4):502-510. doi: 10.1158/1535-7163.MCT-21-0016. Mol Cancer Ther. 2022. PMID: 35086951 Free PMC article.

4

Turnover of the mTOR inhibitor, DEPTOR, and downstream AKT phosphorylation in multiple myeloma cells, is dependent on ERK1-mediated phosphorylation.

Vega M, Chen Y, Shi Y, Gera J, Lichtenstein A. Vega M, et al. Among authors: shi y. J Biol Chem. 2022 Apr;298(4):101750. doi: 10.1016/j.jbc.2022.101750. Epub 2022 Feb 23. J Biol Chem. 2022. PMID: 35216969 Free PMC article.

5

Cytotoxic Properties of a DEPTOR-mTOR Inhibitor in Multiple Myeloma Cells.

Shi Y, Daniels-Wells TR, Frost P, Lee J, Finn RS, Bardeleben C, Penichet ML, Jung ME, Gera J, Lichtenstein A. Shi Y, et al. Cancer Res. 2016 Oct 1;76(19):5822-5831. doi: 10.1158/0008-5472.CAN-16-1019. Epub 2016 Aug 16. Cancer Res. 2016. PMID: 27530328 Free PMC article.

6

Structure-activity relationship study of small molecule inhibitors of the DEPTOR-mTOR interaction.

Lee J, Shi Y, Vega M, Yang Y, Gera J, Jung ME, Lichtenstein A. Lee J, et al. Among authors: shi y. Bioorg Med Chem Lett. 2017 Oct 15;27(20):4714-4724. doi: 10.1016/j.bmcl.2017.09.002. Epub 2017 Sep 6. Bioorg Med Chem Lett. 2017. PMID: 28916338

7

Effect of autophagy on multiple myeloma cell viability.

Hoang B, Benavides A, Shi Y, Frost P, Lichtenstein A. Hoang B, et al. Among authors: shi y. Mol Cancer Ther. 2009 Jul;8(7):1974-84. doi: 10.1158/1535-7163.MCT-08-1177. Epub 2009 Jun 9. Mol Cancer Ther. 2009. PMID: 19509276

8

A Novel Therapeutic Induces DEPTOR Degradation in Multiple Myeloma Cells with Resulting Tumor Cytotoxicity.

Vega MI, Shi Y, Frost P, Huerta-Yepez S, Antonio-Andres G, Hernandez-Pando R, Lee J, Jung ME, Gera JF, Lichtenstein A. Vega MI, et al. Among authors: shi y. Mol Cancer Ther. 2019 Oct;18(10):1822-1831. doi: 10.1158/1535-7163.MCT-19-0115. Epub 2019 Aug 8. Mol Cancer Ther. 2019. PMID: 31395691 Free PMC article.

9

Targeting aurora kinases as therapy in multiple myeloma.

Shi Y, Reiman T, Li W, Maxwell CA, Sen S, Pilarski L, Daniels TR, Penichet ML, Feldman R, Lichtenstein A. Shi Y, et al. Blood. 2007 May 1;109(9):3915-21. doi: 10.1182/blood-2006-07-037671. Epub 2007 Jan 9. Blood. 2007. PMID: 17213289 Free PMC article. Clinical Trial.

10

Acetazolamide affects breathing differently in ICR and C57 mice.

Schlenker E, Shi Y, Johnson C, Wipf J. Schlenker E, et al. Among authors: shi y. Respir Physiol Neurobiol. 2006 Jun;152(2):119-27. doi: 10.1016/j.resp.2005.07.006. Epub 2005 Sep 1. Respir Physiol Neurobiol. 2006. PMID: 16140042

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

34 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year